Home   |   Press   |   Contact   |   Sitemap   
 Investors-Login 
       
  Dr. Christoph Kronabel    

 
Managing Partner
     
         
  Dr. Kronabel was the first member of the HI team in 1997. He is seen as the partner who "keeps the HI clock ticking", taking care of corporate culture and organisational growth. Dr. Kronabel is responsible for transition management within the portfolio and the monitoring of smaller-stake investments.

Dr. Kronabel's academic background is in mathematics, theology and philosophy. He acted as key federal advisor on the restructuring of the medical faculties in Eastern Germany during reunification. Later, Dr. Kronabel built and led the Department for Research, Research Funding and Technology Transfer at the University of Heidelberg.

Dr. Kronabel is currently member of the Investment Committee of EMBL Technology Fund.

Portfolio-Management:

Cenix BioScience GmbH, Dresden
EMBL Technology Fund GmbH & Co. KG, Heidelberg
The Genetics Company, Inc., Schlieren (Switzerland)
 
     
         
  back to the overview